BiVACOR's Total Artificial Heart: Pioneering Heart Replacement Technology

BiVACOR has developed a Total Artificial Heart (TAH) that offers a new lifeline for patients with end-stage heart failure, aiming to bridge the gap to transplantation and potentially serve as a long-term solution.​

Photo source:

Bivacor

Heart failure remains a leading cause of mortality worldwide, with a significant number of patients awaiting heart transplants due to the scarcity of donor organs. Addressing this critical need, BiVACOR has engineered a Total Artificial Heart (TAH) designed to replicate the functions of a natural heart, thereby offering hope to those with severe heart failure.

Innovative Design and Functionality

The BiVACOR TAH distinguishes itself through several key features:​

  • Single Moving Part: The device incorporates a magnetically levitated rotor that serves as the sole moving component, reducing mechanical wear and enhancing durability.

  • Dual Circulation Support: This rotor simultaneously pumps blood to both systemic and pulmonary circulations, effectively replacing the function of both ventricles.

  • Compact and Durable: Constructed from titanium, the TAH is designed to fit within the chest cavity of most adults, offering a robust and biocompatible solution.

Clinical Milestones

BiVACOR's TAH has achieved significant clinical milestones:​

  • First-in-Human Implantation: In July 2024, surgeons at Baylor St. Luke’s Medical Center in Houston successfully implanted the BiVACOR TAH into a patient with end-stage heart failure, marking a pivotal moment in artificial heart technology.

  • Subsequent Implants: Following the initial success, additional implantations have been performed, including a notable case at Duke University Hospital where the TAH effectively supported a patient until a donor heart became available.

Future Outlook

As clinical trials progress, the BiVACOR TAH holds the potential to transform the landscape of heart failure treatment, providing a viable option for patients who may not have access to timely heart transplants. Ongoing research and development aim to refine the device further, enhancing its functionality and patient compatibility.

Lock

You have exceeded your free limits for viewing our premium content

Please subscribe to have unlimited access to our innovations.